Mar. 2026
Japanese association of IgG4-related disease, Excellent Presentation Award, 17th Japanese Conference on IgG4-Related Diseases

Sep. 2025
the Japan College of Rheumatology, The 27th Asia-Pacific League of Associations for Rheumatology Congress Travel Award on JCR

Jun. 2025
2023 Annual Meeting of the Japanese Society of Osteoimmunology, Travel Grant

May 2025
The 4th International Symposium of Clinical Immunology, Young Investigators’ Award
Tissue-Resident Memory T cell Differentiation and Pathological Relevance in Systemic Lupus Erythematosus
Yuya Fujita

Apr. 2025
The 69th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology, JCR 2025 ICW Excellent Abstract Award

Apr. 2022
The 66th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology, JCR 2022 ICW Excellent Abstract Award

Apr. 2021
The 65th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology, JCR 2021 ICW Excellent Abstract Award

Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST Registry
Satoshi Kubo; Yoshiya Tanaka; Yusuke Miyazaki; Hiroaki Tanaka; Hidenori Sakai; Ryuichiro Kanda; Yuya Fujita; Masanobu Ueno; Yasuyuki Todoroki; Ippei Miyagawa; Shingo Nakayamada
RMD Open, Apr. 2026

Effectiveness and safety of sarilumab in polymyalgia rheumatica: A retrospective study of the FIRST registry
Naoaki Ohkubo; Yusuke Miyazaki; Satoshi Kubo; Ippei Miyagawa; Koshiro Sonomoto; Yoshino Inoue; Yurie Satoh-Kanda; Hiroaki Tanaka; Masanobu Ueno; Atsushi Nagayasu; Takafumi Aritomi; Ryuichiro Kanda; Yuya Fujita; Masashi Funada; Hidenori Sakai; Kiyotake Yoshioka; Mayu Nishimoto; Kazuki Takahashi; Shingo Nakayamada; Yoshiya Tanaka
Modern Rheumatology, Mar. 2026

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational study
Takafumi Aritomi; Koshiro Sonomoto; Shingo Nakayamada; Hiroaki Tanaka; Atsushi Nagayasu; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Naoaki Ohkubo; Yasuyuki Todoroki; Yurie Satoh‐Kanda; Masanobu Ueno; Ryuichiro Kanda; Yuya Fujita; Masashi Funada; Hidenori Sakai; Satsuki Matsunaga; Hiroaki Tanaka; Masayuki Shinojima; Hiroki Kawamura; Kazuki Takahashi; Miyabi Ando; Kazuki Haru; Yusuke Miyazaki; Kentaro Hanami; Masao Nawata; Shunsuke Fukuyo; Keisuke Nakatsuka; Mikiko Tokunaga; Kazuyoshi Saito; Yoshiya Tanaka
Arthritis & Rheumatology, Mar. 2026

Real-world effectiveness of b/tsDMARD switching in low-inflammatory difficult-to-treat rheumatoid arthritis: insights from the FIRST registry.
Hidenori Sakai; Koshiro Sonomoto; Shingo Nakayamada; Masanobu Ueno; Atsushi Nagayasu; Takafumi Aritomi; Hiroaki Tanaka; Satoshi Kubo; Ippei Miyagawa; Yasuyuki Todoroki; Yurie Satoh-Kanda; Yuya Fujita; Ryuichiro Kanda; Yoshiya Tanaka
RMD open, Feb. 2026

Predicting the progression of difficult-to-treat rheumatoid arthritis by a machine learning scoring system, from the FIRST registry.
Masanobu Ueno; Koshiro Sonomoto; Hiroaki Tanaka; Atsushi Nagayasu; Takafumi Aritomi; Ippei Miyagawa; Satoshi Kubo; Yusuke Miyazaki; Yasuyuki Todoroki; Yurie Satoh-Kanda; Yuya Fujita; Hidenori Sakai; Shingo Nakayamada; Yoshiya Tanaka
RMD open, Jan. 2026

Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from the FIRST registry
Satoshi Kubo; Yusuke Miyazaki; Hiroaki Tanaka; Yuya Fujita; Hidenori Sakai; Masanobu Ueno; Yasuyuki Todoroki; Yurie Satoh-Kanda; Ippei Miyagawa; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology, Sep. 2025

Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
Atsushi Nagayasu; Yusuke Miyazaki; Koshiro Sonomoto; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Hiroaki Tanaka; Yasuyuki Todoroki; Masanobu Ueno; Takafumi Aritomi; Yuya Fujita; Hidenori Sakai; Katsunori Suzuki; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology and therapy, Aug. 2025

The Diagnostic Value of Contrast‐Enhanced Vessel Wall MRI for Diagnosing Neuropsychiatric Systemic Lupus Erythematosus
Satoru Ide; Yuya Fujita; Yu Murakami; Koichiro Futatsuya; Yuta Yoshimatsu; Jun Tsukamoto; Haruka Oku; Toshihiro Sakamoto; Yoshiya Tanaka; Takatoshi Aoki
Journal of Magnetic Resonance Imaging, May 2025

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Ryuichiro Kanda; Yusuke Miyazaki; Shingo Nakayamada; Shunsuke Fukuyo; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Yurie Satoh-Kanda; Naoaki Ohkubo; Yasuyuki Todoroki; Hiroaki Tanaka; Masanobu Ueno; Atsushi Nagayasu; Yuya Fujita; Takafumi Aritomi; Katsuhide Kusaka; Hidenori Sakai; Satsuki Matsunaga; Hirotsugu Nohara; Yoshiya Tanaka
Rheumatology and therapy, Apr. 2025

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness
Satoshi Kubo; Yusuke Miyazaki; Takahiro Nishino; Yuya Fujita; Michihiro Kono; Tsugumi Kawashima; Kazuyoshi Ishigaki; Katsuhide Kusaka; Hiroaki Tanaka; Masanobu Ueno; Yurie Satoh-Kanda; Yoshino Inoue; Yasuyuki Todoroki; Ippei Miyagawa; Kentaro Hanami; Shingo Nakayamada; Yoshiya Tanaka
Annals of the Rheumatic Diseases, Feb. 2025

Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus
Yuya Fujita; Shingo Nakayamada; Satoshi Kubo; Yusuke Miyazaki; Koshiro Sonomoto; Hiroaki Tanaka; Yoshiya Tanaka
RMD Open, Feb. 2025

A case of Buerger’s disease with vasculopathy and skin fibrosis requiring differential diagnosis from systemic sclerosis
Masashi Funada; Shingo Nakayamada; Shunsuke Fukuyo; Satoshi Kubo; Aya Nawata; Yuya Fujita; Yoshiya Tanaka
Modern Rheumatology Case Reports, Jan. 2025

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study
Koshiro Sonomoto; Shingo Nakayamada; Yoshihisa Fujino; Hiroko Miyata; Satoshi Kubo; Yuya Fujita; Yoshino Inoue; Satsuki Matsunaga; Shigeru Iwata; Kentaro Hanami; Yasuyuki Todoroki; Hiroko Yoshinari-Korekoda; Akio Kawabe; Ayako Yamaguchi; Masanobu Ueno; Yurie Satoh-Kanda; Ryuichiro Kanda; Masashi Funada; Naoaki Ohkubo; Katsuhide Kusaka; Shumpei Kosaka; Atsushi Nagayasu; Shunsuke Fukuyo; Masao Nawata; Yusuke Miyazaki; Mikiko Tokunaga; Kenichi Tanaka; Yosuke Okada; Yoshiya Tanaka
Rheumatology, Aug. 2024

Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus
Yurie Satoh-Kanda; Shingo Nakayamada; Satoshi Kubo; Kaoru Yamagata; Aya Nawata; Hiroaki Tanaka; Shunpei Kosaka; Ryuichiro Kanda; Shan Yu; Yuya Fujita; Koshiro Sonomoto; Yoshiya Tanaka
RMD Open, Jun. 2024

Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis
Yoichi Nakayama; Wataru Nagata; Yoichi Takeuchi; Sho Fukui; Yuya Fujita; Yohei Hosokawa; Masanobu Ueno; Kumiko Ono; Shuji Sumitomo; Yuya Tabuchi; Yuichiro Nakanishi; Shuntaro Saito; Hiroko Ikeuchi; Kazutaka Kawamori; Hideaki Sofue; Goro Doi; Runa Minami; Tomoya Hirota; Kaoru Minegishi; Keisuke Maeshima; Ryo Motoyama; Shohei Nakamura; Shotaro Suzuki; Norihiro Nishioka; Takuma Tsuzuki Wada; Akira Onishi; Kenichi Nishimura; Ryu Watanabe; Ryo Yanai; Takashi Kida; Hiroki Nishiwaki; Nobuyuki Yajima; Yuko Kaneko; Eiichi Tanaka; Yutaka Kawahito; Masayoshi Harigai
Modern Rheumatology, May 2024

Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus
Yuya Fujita; Shigeru Iwata; Shinsuke Hidese; Sayuri Ishiwata; Satoru Ide; Hiroaki Tanaka; Koshiro Sonomoto; Yusuke Miyazaki; Shingo Nakayamada; Atsuko Ikenouchi; Kotaro Hattori; Hiroshi Kunugi; Reiji Yoshimura; Yoshiya Tanaka
Rheumatology, Oct. 2023

Usefulness of ultrasound as a predictor of elderly-onset rheumatoid arthritis with polymyalgia rheumatica-like onset
Masao Nawata; Kazuki Someya; Shunpei Kosaka; Takafumi Aritomi; Masashi Funada; Yuya Fujita; Atsushi Nagayasu; Yoshihisa Fujino; Kazuyoshi Saito; Yoshiya Tanaka
Modern Rheumatology, Mar. 2023

TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus
Yu Shan; Shingo Nakayamada; Aya Nawata; Kaoru Yamagata; Koshiro Sonomoto; Hiroaki Tanaka; Yurie Satoh-Kanda; Mai-Phuong Nguyen; Yasuyuki Todoroki; Atsushi Nagayasu; Masanobu Ueno; Ryuichiro Kanda; Yuya Fujita; Tong Zhang; He Hao; Jieqing Zhou; Xiaoxue Ma; Junpei Anan; Anh Phuong Nguyen; Yoshiya Tanaka
Rheumatology, Nov. 2022

mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitors.
Mingzeng Zhang; Shigeru Iwata; Koshiro Sonomoto; Masanobu Ueno; Yuya Fujita; Junpei Anan; Yusuke Miyazaki; Naoaki Ohkubo; Maiko Hajime Sumikawa; Yasuyuki Todoroki; Hiroko Miyata; Atsushi Nagayasu; Ryuichiro Kanda; He Hao; Gulzhan Trimova; Seunghyun Lee; Shingo Nakayamada; Kei Sakata; Yoshiya Tanaka
Rheumatology (Oxford, England), Jul. 2022

A case of simultaneous onset of highly active systemic lupus erythematosus and IgG4-related renal disease
Yuya Fujita; Shigeru Iwata; Kazuhisa Nakano; Shingo Nakayamada; Yusuke Miyazaki; Akio Kawabe; Hiroko Korekoda-Yoshinari; Aya Nawata; Yoshiya Tanaka
Modern Rheumatology Case Reports, Jan. 2022

Association between ultrasound images and patient-reported outcomes in the treatment of rheumatoid arthritis: a retrospective study
Masao Nawata; Kazuki Someya; Masashi Funada; Yuya Fujita; Atsushi Nagayasu; Kazuyoshi Saito; Yoshiya Tanaka
BMC Rheumatology, Nov. 2021

Neuropsychiatric systemic lupus erythematosus detected using extravascular spillage signal on dynamic magnetic resonance imaging (Ktrans)
Yuya Fujita; Shigeru Iwata; Kazuhisa Nakano; Hiroaki Adachi; Yoshiya Tanaka
Rheumatology, Oct. 2021

Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report
Masao Nawata; Atsushi Nagayasu; Yuya Fujita; Aya Nawata; Kazuyoshi Saito; Yoshiya Tanaka
Lupus, Sep. 2020

The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
Ippei Miyagawa; Kazuhisa Nakano; Shingo Nakayamada; Shigeru Iwata; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Akio Kawabe; Yusuke Miyazaki; Yoshino Inoue; Masanobu Ueno; Naoaki Ohkubo; Yuya Fujita; Yoshiya Tanaka
International journal of rheumatic diseases, Apr. 2020

Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report
Yuya Fujita; Masao Nawata; Atsushi Nagayasu; Kazuki Someya; Kazuyoshi Saito; Yoshiya Tanaka
Case Reports in Rheumatology, Jul. 2019

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo Satoshi, Miyazaki Yusuke, Nishino Takahiro, Fujita Yuya, Kono Michihiro, Kawashima Tsugumi, Ishigaki Kazuyoshi, Kusaka Katsuhide, Tanaka Hiroaki, Ueno Masanobu, Satoh-Kanda Yurie, Inoue Yoshino, Todoroki Yasuyuki, Miyagawa Ippei, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Annals of the rheumatic diseases, Oct. 2024, Reviewed, No invitation

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo Satoshi, Miyazaki Yusuke, Nishino Takahiro, Fujita Yuya, Kono Michihiro, Kawashima Tsugumi, Ishigaki Kazuyoshi, Kusaka Katsuhide, Tanaka Hiroaki, Ueno Masanobu, Satoh-Kanda Yurie, Inoue Yoshino, Todoroki Yasuyuki, Miyagawa Ippei, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Annals of the rheumatic diseases, Feb. 2025, Reviewed, No invitation

Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report.
Fujita Yuya, Nawata Masao, Nagayasu Atsushi, Someya Kazuki, Saito Kazuyoshi, Tanaka Yoshiya
Case reports in rheumatology, Jul. 2019, Reviewed, No invitation
Lead

A refractory case of a male patient with neuropsychiatric systemic lupus erythematosus with various psychiatric symptoms and MRI observations
Reia Hashimoto, Asuka Katsuki, Yuya Fujita, Atsuko Ikenouchi, Yoshiya Tanaka, Reiji Yoshimura
Clinical Neuropsychopharmacology and Therapeutics, Feb. 2020, Reviewed, No invitation

The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
Miyagawa Ippei, Nakano Kazuhisa, Nakayamada Shingo, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Kawabe Akio, Miyazaki Yusuke, Inoue Yoshino, Ueno Masanobu, Ohkubo Naoaki, Fujita Yuya, Tanaka Yoshiya
International journal of rheumatic diseases, Feb. 2020, Reviewed, No invitation

A case of Buerger's disease with vasculopathy and skin fibrosis requiring differential diagnosis from systemic sclerosis
Masashi Funada, Shingo Nakayamada, Shunsuke Fukuyo, Satoshi Kubo, Aya Nawata, Yuya Fujita, Yoshiya Tanaka
Modern Rehumatology Case Reports, Jan. 2025, Reviewed, No invitation

Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.
Nakayama Yoichi, Nagata Wataru, Takeuchi Yoichi, Fukui Sho, Fujita Yuya, Hosokawa Yohei, Ueno Masanobu, Ono Kumiko, Sumitomo Shuji, Tabuchi Yuya, Nakanishi Yuichiro, Saito Shuntaro, Ikeuchi Hiroko, Kawamori Kazutaka, Sofue Hideaki, Doi Goro, Minami Runa, Hirota Tomoya, Minegishi Kaoru, Maeshima Keisuke, Motoyama Ryo, Nakamura Shohei, Suzuki Shotaro, Nishioka Norihiro, Wada Takuma Tsuzuki, Onishi Akira, Nishimura Kenichi, Watanabe Ryu, Yanai Ryo, Kida Takashi, Nishiwaki Hiroki, Yajima Nobuyuki, Kaneko Yuko, Tanaka Eiichi, Kawahito Yutaka, Harigai Masayoshi
Modern rheumatology, Oct. 2024, Reviewed, No invitation

A case of Buerger's disease with vasculopathy and skin fibrosis requiring differential diagnosis from systemic sclerosis.
Funada Masashi, Nakayamada Shingo, Fukuyo Shunsuke, Kubo Satoshi, Nawata Aya, Fujita Yuya, Tanaka Yoshiya
Modern rheumatology case reports, Jul. 2024, Reviewed, No invitation

Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus.
Fujita Yuya, Nakayamada Shingo, Kubo Satoshi, Miyazaki Yusuke, Sonomoto Koshiro, Tanaka Hiroaki, Tanaka Yoshiya
RMD open, Feb. 2025, Reviewed, No invitation
Lead

Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus.
Satoh-Kanda Yurie, Nakayamada Shingo, Kubo Satoshi, Yamagata Kaoru, Nawata Aya, Tanaka Hiroaki, Kosaka Shunpei, Kanda Ryuichiro, Yu Shan, Fujita Yuya, Sonomoto Koshiro, Tanaka Yoshiya
RMD open, Jun. 2024, Reviewed, No invitation

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Sonomoto Koshiro, Nakayamada Shingo, Fujino Yoshihisa, Miyata Hiroko, Kubo Satoshi, Fujita Yuya, Inoue Yoshino, Matsunaga Satsuki, Iwata Shigeru, Hanami Kentaro, Todoroki Yasuyuki, Yoshinari-Korekoda Hiroko, Kawabe Akio, Yamaguchi Ayako, Ueno Masanobu, Satoh-Kanda Yurie, Kanda Ryuichiro, Funada Masashi, Ohkubo Naoaki, Kusaka Katsuhide, Kosaka Shumpei, Nagayasu Atsushi, Fukuyo Shunsuke, Nawata Masao, Miyazaki Yusuke, Tokunaga Mikiko, Tanaka Kenichi, Okada Yosuke, Tanaka Yoshiya
Rheumatology (Oxford, England), Nov. 2023, Reviewed, No invitation

Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from FIRST registry.
Kubo Satoshi, Miyazaki Yusuke, Tanaka Hiroaki, Fujita Yuya, Sakai Hidenori, Ueno Masanobu, Todoroki Yasuyuki, Satoh-Kanda Yurie, Miyagawa Ippei, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology (Oxford, England), May 2025, Reviewed, No invitation

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Kanda Ryuichiro, Miyazaki Yusuke, Nakayamada Shingo, Fukuyo Shunsuke, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Satoh-Kanda Yurie, Ohkubo Naoaki, Todoroki Yasuyuki, Tanaka Hiroaki, Ueno Masanobu, Nagayasu Atsushi, Fujita Yuya, Aritomi Takafumi, Kusaka Katsuhide, Sakai Hidenori, Matsunaga Satsuki, Nohara Hirotsugu, Tanaka Yoshiya
Rheumatology and therapy, Mar. 2025, Reviewed, No invitation

Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
Nagayasu Atsushi, Miyazaki Yusuke, Sonomoto Koshiro, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Tanaka Hiroaki, Todoroki Yasuyuki, Ueno Masanobu, Aritomi Takafumi, Fujita Yuya, Sakai Hidenori, Suzuki Katsunori, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology and therapy, Aug. 2025, Reviewed, No invitation